Quadrature Capital’s Sanara MedTech SMTI Stock Holding History

Quadrature Capital’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$250K	Buy	10,588 +416	+4%	+$8.6K	﹤0.01%	1277
2026 Q1	$175K	Buy	+10,172	New	+$209K	﹤0.01%	1148
2024 Q2	–	Sell	-6,616	Closed	-$244K	–	1507
2024 Q1	$244K	Sell	6,616 -236	-3%	-$8.82K	﹤0.01%	984
2023 Q4	$281K	Sell	6,852 -8,775	-56%	-$282K	0.01%	876
2023 Q3	$487K	Sell	15,627 -1,687	-10%	-$65.3K	0.01%	598
2023 Q2	$694K	Buy	17,314 +6,644	+62%	+$272K	0.02%	501
2023 Q1	$440K	Buy	10,670 +6,077	+132%	+$256K	0.01%	586
2022 Q4	$207K	Sell	4,593 -2,294	-33%	-$79K	0.01%	713
2022 Q3	$204K	Buy	+6,887	New	+$193K	0.01%	721

Other funds holding SMTI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

SWM

Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Quadrature Capital's SMTI Position: Q2 2026 in Review

Quadrature Capital increased its Sanara MedTech (SMTI) stake by 4.1% in Q2 2026, buying an estimated $8.6K and bringing the position to 10,588 shares worth $250K. The position accounts for ﹤0.01% of the portfolio, ranked #1277.

Quadrature Capital first reported a position in SMTI in Q3 2022 and has held it in 9 quarters since. The position peaked at $694K in Q2 2023. 74 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

Quadrature Capital held 10,588 shares of Sanara MedTech worth $250K as of Q2 2026.
Quadrature Capital bought 416 Sanara MedTech shares in Q2 2026, an estimated $8.6K.
Sanara MedTech made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1277 holding.
Quadrature Capital first reported a position in Sanara MedTech in Q3 2022 and has held it in 9 quarters since.
Quadrature Capital's Sanara MedTech position peaked at $694K in Q2 2023.
74 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.